Why the study?
Does lower remnant cholesterol reduce recurrent MACE in individuals with a diagnosis of myocardial infarction or ischaemic stroke?
Does lower remnant cholesterol reduce recurrent MACE in individuals with a diagnosis of myocardial infarction or ischaemic stroke?
Lowering remnant cholesterol may significantly reduce recurrent MACE in secondary prevention for patients with prior MI or ischemic stroke.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for remnant cholesterol lowering in secondary prevention; randomized trials needed to confirm effects on recurrent MACE.
In individuals with a diagnosis of myocardial infarction/ischaemic stroke, a lower remnant cholesterol of 0.8 mmol L⁻¹ (32 mg dL⁻¹ ) was estimated to reduce recurrent MACE by 20% in secondary prevention. Our data indicate an unmet medical need for secondary prevention in individuals with high nonfasting remnant cholesterol levels.
No takes yet. Share an insight, caveat, or question.
Langsted et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: